Cargando…

QSPR analysis of some agonists and antagonists of α-adrenergic receptors

Thirty-three compounds belonging to the sympatholytics and sympathomimetics were analyzed during the study. The biological activity data for the parameters of binding affinity to the α(1)- and α(2)-adrenergic receptors together with parameters of the logarithm of the partition coefficient n-octanol/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawczak, Piotr, Bober, Leszek, Bączek, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284397/ https://www.ncbi.nlm.nih.gov/pubmed/25589825 http://dx.doi.org/10.1007/s00044-014-1130-x

Ejemplares similares

Activity evaluation of some psychoactive drugs with the application of QSAR/QSPR modeling methods
por: Kawczak, Piotr, et al.
Publicado: (2018)

Pharmacological Classification and Activity Evaluation of Furan and Thiophene Amide Derivatives Applying Semi-Empirical ab initio Molecular Modeling Methods
por: Bober, Leszek, et al.
Publicado: (2012)

Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
por: Ballesteros, Jesus Javier, et al.
Publicado: (2020)

Suppression of the cough reflex by α(2)-adrenergic receptor agonists in the rabbit
por: Cinelli, Elenia, et al.
Publicado: (2013)

Characterization of β-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with β-adrenergic receptor agonists and antagonists
por: Hwang, Jinhee H, et al.
Publicado: (2021)

Partial agonist activity of α(1)-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3
por: Gao, Xianlong, et al.
Publicado: (2018)

Structural basis of agonist specificity of α(1A)-adrenergic receptor
por: Su, Minfei, et al.
Publicado: (2023)

The Specific α1-Adrenergic Receptor Antagonist Prazosin Influences the Urine Proteome
por: Zhao, Mindi, et al.
Publicado: (2016)

Principal Component Analysis of HPLC Retention Data and Molecular Modeling Structural Parameters of Cardiovascular System Drugs in View of Their Pharmacological Activity
por: Stasiak, Jolanta, et al.
Publicado: (2010)

Effect Of α2-Adrenergic Agonists And Antagonists On Cytokine Release From Human Lung Macrophages Cultured In Vitro
por: Piazza, O., et al.
Publicado: (2016)

Effects of Adrenergic Agonists and Antagonists on Cardiopulmonary Function During Normobaric Hypoxia in Rat
por: Bölter, Christian, et al.
Publicado: (2019)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
por: Komaki, Alireza, et al.
Publicado: (2014)

Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011)

The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β(2) Adrenergic Receptor Agonist Navafenterol in Human Small Airways
por: Jude, Joseph Antony, et al.
Publicado: (2023)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone
por: Støve, Svein Isungset, et al.
Publicado: (2022)

Characterization of antimicrobial and hemolytic properties of short synthetic cationic lipopeptides based on QSAR/QSTR approach
por: Greber, Katarzyna E., et al.
Publicado: (2017)

QSPR Modeling of Bioconcentration Factors of Nonionic Organic Compounds
por: Deeb, Omar, et al.
Publicado: (2010)

Sustained Hypoxic Pulmonary Vasoconstriction in the Isolated Perfused Rat Lung: Effect of α(1)-adrenergic Receptor Agonist
por: Ketabchi, Farzaneh, et al.
Publicado: (2014)

In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea
por: Piwnica, David, et al.
Publicado: (2018)

Development and validation of QSPR models for corrosion inhibition of carbon steel by some pyridazine derivatives in acidic medium
por: El Assiri, El Hassan, et al.
Publicado: (2020)

QSPR designer – a program to design and evaluate QSPR models. Case study on pK(a) prediction
por: Skřehota, O, et al.
Publicado: (2011)

Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α(1A)/α(1D)-Adrenergic Receptor Antagonist with Potential Uroselective Profile
por: Canale, Vittorio, et al.
Publicado: (2018)

An Improved QSPR Modeling of Hydrocarbon Dipole Moments
por: Nesterov, Igor V., et al.
Publicado: (2004)

QSPR Modeling of Fungicides Using Topological Descriptors
por: Parveen, Saima, et al.
Publicado: (2023)

BioPPSy: An Open-Source Platform for QSAR/QSPR Analysis
por: Enciso, Marta, et al.
Publicado: (2016)

Degree-based topological indices on anticancer drugs with QSPR analysis
por: Shanmukha, M.C., et al.
Publicado: (2020)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection
por: Nizari, Shereen, et al.
Publicado: (2016)

Altered Expression Profile of Renal α (1D)-Adrenergic Receptor in Diabetes and Its Modulation by PPAR Agonists
por: Zhao, Xueying, et al.
Publicado: (2014)

Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007)

Staying awake – a genetic region that hinders α(2) adrenergic receptor agonist-induced sleep
por: Gelegen, Cigdem, et al.
Publicado: (2014)

Clonidine, an α2 adrenergic receptor agonist, disrupts reconsolidation of a cocaine-paired environmental memory
por: Denny, Rachel R., et al.
Publicado: (2019)

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
por: Wolter, Jennifer K, et al.
Publicado: (2013)

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor
por: Warne, Tony, et al.
Publicado: (2011)

Adrenergic receptor agonists/hydrocortisone: Lack of efficacy: case report
Publicado: (2021)

Forearm vasodilator responses to a β‐adrenergic receptor agonist in premenopausal and postmenopausal women
por: Harvey, Ronee E., et al.
Publicado: (2014)

A Review on Progress in QSPR Studies for Surfactants
por: Hu, Jiwei, et al.
Publicado: (2010)

QSPR/QSAR: State-of-Art, Weirdness, the Future
por: Toropov, Andrey A., et al.
Publicado: (2020)

Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
por: Lee, Sehan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gi8hq5nbv9hvjs9v4ifctsu2eb